
GlaxoSmithKline Pakistan is a biopharma company making specialty medicines and vaccines, and general medicines prescribed in primary and community care.
pk.gsk.comCrawled Nov 12, 2026
Learn about more about our portfolio of vaccines, specialty and general medicines.
We make a wide range of prescription medicines and vaccines
Here you can find the full A-Z list of our products available worldwide.
GSK combines genetics, genomics, and advanced technologies to create effective vaccines and medicines.
Embracing digitalisation is central to GSK’s new commitments to vaccine innovation
Our innovation uses human genetics, genomics and advanced technologies to develop more effective vaccines and medicines
An adjuvant, derived from the Latin word for 'help,' enhances the immune response.
Latest press releases, media assets and global media contacts
GSK provides media relations contact details.
Bringing together outstanding people and doing work that matters in an inclusive environment.
Our Early Talent programmes help you hit the ground running as you enter the world of work.
GSK answers common questions about its hiring process.
Our Board has established a corporate governance framework with clearly defined responsibilities and accountabilities.
We are a science-led global healthcare company with a special purpose.
GSK Pakistan Limited has been providing trusted quality medicines and vaccines, to more than 200 million people all over Pakistan.
GSK outlines views and practices on issues important to patients and stakeholders.
Whether you’re a customer, job seeker, health professional or an investor, you can find the best way to contact us .
GSK lists its locations in Pakistan.
Adverse Events must be reported.
GSK's corporate Pakistan website terms of use
Pakistan’s listed pharmaceutical companies report an 11% profit increase in 1QFY27, reaching **Rs11.6 billion**. GlaxoSmithKline Pakistan Limited drives sector sales, contributing **17%** of total revenue. The growth reflects stronger financial performance across the industry’s publicly traded firms.
Nov 2026BrecorderNews article
GlaxoSmithKline Pakistan Limited names Dmytro Oliinyk, VP Head of Finance for GSK’s International Region, as Non-Executive Director and Chairperson. The appointment fills a vacancy created by Lai Kuen Goh’s resignation from the Board of Directors. Oliinyk assumes the role with immediate effect, overseeing strategic governance for the local subsidiary.
Apr 2026BrecorderNews article
Pakistan’s Rawalpindi Drug Court sentences the CEO and employees of **GlaxoSmithKline (GSK)** to imprisonment and fines over substandard medicine allegations. GSK denies any wrongdoing and plans to appeal the verdict. The case marks an unusual legal outcome against a pharmaceutical company.
Apr 2024DawnNews article
GlaxoSmithKline Pakistan Limited reports declining profits for the first half of the fiscal year 2022 (1HCY22). The company, which manufactures and markets prescription medicines and vaccines, faces challenges from rising inflation and increased cost pressures.
Sep 2022BrecorderNews article